Predicting the risk of hepatocellular carcinoma in 116,404 cirrhotic patients according to etiology of cirrhosis.

Ioannou George N.; Berry Kristin; Lowy Elliott

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Predicting the risk of hepatocellular carcinoma in 116,404 cirrhotic patients according to etiology of cirrhosis.

【24h】

Predicting the risk of hepatocellular carcinoma in 116,404 cirrhotic patients according to etiology of cirrhosis.

机译：根据肝硬化病因，预测116,404例肝硬化患者肝细胞癌的风险。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2017年第1期|共2页
作者
Ioannou George N.; Berry Kristin; Lowy Elliott;
展开▼
作者单位

Univ Washington Seattle WA 98195 USA;

Vet Affairs Puget Sound Healthcare Syst Seattle WA USA;

Vet Affairs Puget Sound Healthcare Syst Seattle WA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Predicting the risk of hepatocellular carcinoma in 116,404 cirrhotic patients according to etiology of cirrhosis. [J] . Ioannou George N., Berry Kristin, Lowy Elliott Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：根据肝硬化病因，预测116,404例肝硬化患者肝细胞癌的风险。
2. Short-term risk of de novo hepatocellular carcinoma in cirrhotic patients treated with DAAs compared to untreated cirrhotic patients [J] . Romano Antonietta, Tonon Marta, Azzolini Matteo, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：与未经处理的肝硬化患者相比，DAA治疗肝硬化患者肝硬化患者的短期风险
3. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. [J] . Chiesa R, Donato F, Tagger A, Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research . 2000,第2期

机译：意大利有无肝硬化患者的肝细胞癌病因学。
4. Hepatocellular carcinoma, cholangiocarcinoma, colon and pancreatic carcinoma in patients with primary sclerosing cholangitis: epidemiology and risk factors [C] . U. BROOME, A. BERGQUIST Falk Liver Week . 2004

机译：肝细胞癌，胆管癌，结肠癌和初级硬化性胆管炎患者的胰腺癌：流行病学和风险因素
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients [O] . Kung-Hao Liang, Ming-Wei Lai, Yang-Hsiang Lin, 2021

机译：血浆白细胞介素-17和α-胎蛋白组合有效地预测肝硬化患者的迫在眉睫的肝细胞癌发生
7. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis [O] . Libbrecht Louis, Craninx M, Nevens F, 2001

机译：肝细胞发育不良对非肝硬化和肝硬化慢性病毒性肝炎患者发展或肝细胞癌的预测价值

Predicting the risk of hepatocellular carcinoma in 116,404 cirrhotic patients according to etiology of cirrhosis.

著录项

相似文献

相关主题

期刊订阅